TRi-1

CAS No. 246020-68-8

TRi-1 ( —— )

Catalog No. M20217 CAS No. 246020-68-8

TRi-1 is irreversible inhibitor of?cytosolic thioredoxin reductase 1 (TXNRD1) with an?IC50?of 12 nM. TRi-1 has little mitochondrial toxicity for anticancer therapy.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 86 In Stock
5MG 132 In Stock
10MG 205 In Stock
25MG 340 In Stock
50MG 484 In Stock
100MG 700 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    TRi-1
  • Note
    Research use only not for human use.
  • Brief Description
    TRi-1 is irreversible inhibitor of?cytosolic thioredoxin reductase 1 (TXNRD1) with an?IC50?of 12 nM. TRi-1 has little mitochondrial toxicity for anticancer therapy.
  • Description
    TRi-1 is irreversible inhibitor of?cytosolic thioredoxin reductase 1 (TXNRD1) with an?IC50?of 12 nM. TRi-1 has little mitochondrial toxicity for anticancer therapy.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    TXNRD1
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    246020-68-8
  • Formula Weight
    328.72
  • Molecular Formula
    C12H9ClN2O5S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:62.5 mg/mL?(190.13 mM)
  • SMILES
    COc1ccc(c(n1)S(=O)(=O)c1ccc(Cl)cc1)[N+]([O-])=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Stafford WC et al. Irreversible inhibition of cytosolic thioredoxin reductase 1 as a mechanistic basis for anticancer therapy. Sci Transl Med. 2018 Feb 14;10(428). pii: eaaf7444.
molnova catalog
related products